NCT05176496View on ClinicalTrials.gov

A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment

CompletedOBSERVATIONAL
Enrollment

99,999

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

July 15, 2023

Study Completion Date

July 15, 2023

Conditions
Heavy Menstrual Bleeding
Trial Locations (1)

13342

Bayer, Berlin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT05176496 - A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment | Biotech Hunter | Biotech Hunter